Showing results (451-460 of 635) with videos related to
Sort By:
Pageof 64
European Heart Journal|May 28, 2026
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysisRyohei Ono, Misato Chimura, Kieran F Docherty, et al.Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.Journal of the American College of Cardiology|August 27, 2025
Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Mats C Højbjerg Lassen, Jawad H Butt, et al.Journal of the American College of Cardiology|September 2, 2025
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Brendon L Neuen, Brian L Claggett, et al.European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.Circulation|September 29, 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF TrialKieran F Docherty, Alasdair D Henderson, Pardeep S Jhund, et al.Journal of the American College of Cardiology|January 6, 2026
Predicting Heart Failure From 12-Lead ECGs Using AI: A HeartShare/AMP-HF Pooled Cohort AnalysisAkshay S Desai, Ambarish Pandey, Rohit Suratekar, et al.JACC. Heart Failure|April 15, 2025
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.Journal of the American College of Cardiology|August 3, 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJasper Tromp, Li Shen, Pardeep S Jhund, et al.Pageof 64